Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (4641)	4/19/2006 7:12:23 PM
From: nigel bates	Respond to of 4974

On the programs that make it - absolutely. (That's what ticked me off about the price ABGX got knocked down for...) The more interesting question is whether four years is enough to tell ?

To: rkrw who wrote (4641)	11/22/2006 1:30:07 PM
From: dr.praveen	Read Replies (1) \| Respond to of 4974

Synta...Help..Push me out of the gate :-) Synta files $115M IPO Perhaps buoyed by a string of positive data, Synta Pharmaceuticals is filing a $115 million IPO despite the risky biotech IPO climate. The Lexington, MA biotech has yet to determine the number of shares to be offered and the price range for the offering. Earlier this month the FDA granted Synta fast-track status for its lead oncology drug candidate, STA-4783. Synta is developing small molecule drugs for a number of indications, including cancer and chronic inflammatory diseases.